Results for Cardiovascular Diseases

1 - 10 of 92

Dr. Jill Savla is an attending cardiologist at Children's Hospital of Philadelphia. Her research interests include congenital heart disease, early life risk factors for congenital heart surgery, maternal-fetal environment, outcomes research, and clinical epidemiology.

E-mail:

savlaj [at] chop.edu

Danielle S. Burstein, MD

Dr. Burstein's research primarily involves the epidemiology and outcomes of cardiovascular disease in children with heart failure and heart transplantation. She is most interested in better understanding the role of safe exercise in children with heart failure and congenital heart disease.

E-mail:

bursteind [at] chop.edu

Harry Ischiropoulos, PhD

Dr. Ischiropoulos's research objectives are to develop and test novel therapeutics for long-chain fatty acid oxidation (LCFA) disorders, a collection of inherited metabolic diseases that affect the heart, liver and muscle. A second area of interest is the resolution of the nitric oxide signaling pathways at the proteome level in the cardiovascular and neuronal systems.

E-mail:

ischirop [at] pennmedicine.upenn.edu

Joseph W. Rossano, MD

Dr. Rossano's extensive research experience primarily involves the epidemiology and outcomes of cardiovascular disease in children, and multi-institutional collaborative observational and interventional studies. His particular research interests include evaluating the treatment and outcomes of pediatric cardiomyopathy, heart failure, and transplantation.

E-mail:

rossanoj [at] chop.edu

Stephanie L. Mayne, PhD, MHS

Dr. Mayne is an epidemiologist whose research focuses on preventing cardiovascular disease and promoting healthy behaviors in children and their families. She employs multilevel and longitudinal methods to study how factors at the individual, family, neighborhood, and policy level influence risk factor behaviors and cardiometabolic outcomes. She is also engaged in research to promote innovation in pediatric primary care.

E-mail:

maynes [at] chop.edu

Daniel P. Kelly, MD

Dr. Kelly’s research career began with deciphering the genetic basis of inborn errors in metabolism in children, followed by a series of breakthrough discoveries relevant to the diagnosis and treatment of common forms of heart failure in the general population.

E-mail:

dankelly [at] pennmedicine.upenn.edu

Justin Berger, MD, PhD

Dr. Berger's research focus involves the development of pediatric heart failure and underlying metabolic drivers. He studies how improving metabolic dysregulation may also benefit cardiac dysfunction.

E-mail:

bergerj [at] chop.edu

Geary "Chip" Smith, DVM, MS

Dr. Smith is a laboratory animal medicine veterinarian. As Technical Director of the CCMT Comparative Medicine Services Core, he helps guide promising therapeutics and devices from discovery and developmental studies through nonclinical studies.

E-mail:

smithgr [at] chop.edu

Michael Chorny, PhD

Dr. Chorny's research program focuses on nanomedicines as well as drug, cell, and gene delivery systems for treating proliferative disease. His current research specifically focuses on the use of nanoparticle-mediated delivery to solid tumors and site-specific delivery for cardiovascular disease.

E-mail:

chorny [at] chop.edu

Matthew A. Deardorff , MD, PhD

Dr. Deardorff’s work integrates patient information with genomics and cell biology to diagnosis and understand rare genetic disease. His research focuses on disorders caused by dysregulation of chromatin or altered translational regulation, specifically, Cornelia de Lange, Coffin-Siris, Skraban-Deardorff and KBG syndromes.

E-mail:

deardorff [at] chop.edu